1. Home
  2. PAHC vs BBNX Comparison

PAHC vs BBNX Comparison

Compare PAHC & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • BBNX
  • Stock Information
  • Founded
  • PAHC 1946
  • BBNX 2015
  • Country
  • PAHC United States
  • BBNX United States
  • Employees
  • PAHC N/A
  • BBNX N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • BBNX Medical/Dental Instruments
  • Sector
  • PAHC Health Care
  • BBNX Health Care
  • Exchange
  • PAHC Nasdaq
  • BBNX Nasdaq
  • Market Cap
  • PAHC 871.9M
  • BBNX 866.3M
  • IPO Year
  • PAHC 2014
  • BBNX 2025
  • Fundamental
  • Price
  • PAHC $21.95
  • BBNX $12.05
  • Analyst Decision
  • PAHC Sell
  • BBNX Strong Buy
  • Analyst Count
  • PAHC 4
  • BBNX 6
  • Target Price
  • PAHC $21.00
  • BBNX $26.67
  • AVG Volume (30 Days)
  • PAHC 242.0K
  • BBNX 670.8K
  • Earning Date
  • PAHC 05-07-2025
  • BBNX 05-06-2025
  • Dividend Yield
  • PAHC 2.19%
  • BBNX N/A
  • EPS Growth
  • PAHC 30.53
  • BBNX N/A
  • EPS
  • PAHC 0.48
  • BBNX N/A
  • Revenue
  • PAHC $1,106,080,000.00
  • BBNX $65,123,999.00
  • Revenue This Year
  • PAHC $28.43
  • BBNX $29.49
  • Revenue Next Year
  • PAHC $10.10
  • BBNX $34.93
  • P/E Ratio
  • PAHC $46.07
  • BBNX N/A
  • Revenue Growth
  • PAHC 12.63
  • BBNX 442.93
  • 52 Week Low
  • PAHC $12.30
  • BBNX $11.11
  • 52 Week High
  • PAHC $26.55
  • BBNX $24.50
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 45.76
  • BBNX N/A
  • Support Level
  • PAHC $20.80
  • BBNX N/A
  • Resistance Level
  • PAHC $22.41
  • BBNX N/A
  • Average True Range (ATR)
  • PAHC 0.66
  • BBNX 0.00
  • MACD
  • PAHC 0.01
  • BBNX 0.00
  • Stochastic Oscillator
  • PAHC 50.56
  • BBNX 0.00

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product include the iLet Bionic Pancreas (iLet). The Company operates as single segment, focused on the development, manufacture and sale of the iLet.

Share on Social Networks: